Kaiseraugst, Switzerland

Hans Meier

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Actelion Pharmaceuticals Ltd. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hans Meier. Retrieved from https://idiyas.com/inventor/hans-meier-xzhq1mo7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Hans Meier

Introduction

Hans Meier is a notable inventor based in Kaiseraugst, Switzerland. He has made significant contributions to the field of chemistry, particularly in the development of processes for manufacturing pharmaceutical compounds. His work has implications for the production of antibiotic compounds, showcasing his impact on medical science.

Latest Patents

Hans Meier holds a patent for a "Process for manufacturing naphthyridine derivatives." This invention relates to a new process suitable for manufacturing compounds that serve as synthetic intermediates. These intermediates are essential in the preparation of antibiotic compounds, highlighting the importance of his work in the pharmaceutical industry. He has 1 patent to his name.

Career Highlights

Meier is currently employed at Actelion Pharmaceuticals Ltd., a company known for its innovative approaches to drug development. His role at Actelion has allowed him to further his research and contribute to advancements in the pharmaceutical sector.

Collaborations

Throughout his career, Hans Meier has collaborated with esteemed colleagues such as Heinz Steiner and Stefan Abele. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Hans Meier's contributions to the field of chemistry and pharmaceuticals are noteworthy. His patent for the manufacturing of naphthyridine derivatives exemplifies his innovative spirit and dedication to advancing medical science. His work continues to influence the development of important antibiotic compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…